This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
|Articles|August 19, 2006
The da Vinci™ Robotic Surgical System
Author(s)Marshall Smith, MD
From the 34th Annual Meeting - Chicago, Illinois - November 2005
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
2
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
3
FAQ: Who is a candidate for testosterone therapy in women?
4
FAQ: What does the evidence show about testosterone in women?
5